My site

 Agreements between the Association of Ethiopian Broadcasters, the Ethiopian Broadcasting Cooperation, and SES will enable growth in the local media sector and deliver content exclusively for Ethiopian people

LUXEMBOURG-Tuesday 9 July 2019 [ AETOS Wire ]

(BUSINESS WIRE) -- Ethiopian private and public broadcasters, and the local media market, are poised for growth following two agreements signed between SES and the Association of Ethiopian Broadcasters (AEB), and the Ethiopian Broadcasting Cooperation (EBC) that will result in the creation of a dedicated Ethiopian TV environment. In particular, the AEB agreement will see the most popular Ethiopian TV channels migrate to a new TV neighbourhood hosted by SES’s NSS-12 satellite at 57 degrees East.

Ethiopia currently has more than 4 million TV households that access television service via satellite. The majority of content is currently broadcast from an orbital location that also supplies content to Mi ... Read more »

• First studies to assess treatment and prevention of recurrent venous thromboembolism (VTE) with dabigatran etexilate in children

• The Phase IIb/III DIVERSITY study demonstrated that the efficacy and safety profile of dabigatran was comparable to standard of care (SOC) for the treatment of children with acute VTE1

• A second Phase III study reinforced the safety profile in children with persistent VTE risk factors receiving dabigatran for prevention of recurrent VTE2

INGELHEIM, Germany-Tuesday 9 July 2019 [ AETOS Wire ]

(BUSINESS WIRE) -- Boehringer Ingelheim today announced results from two paediatric studies of dabigatran etexilate, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia.1,2

The data showed dabigatran to be as effective and have a comparable safety profile to the current standard of care (SOC) for the treatment of acute venou ... Read more »

LONDON-Friday 5 July 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- IBC2019 is excited to present brand new thought-provoking, stimulating and disruptive conference tracks and timely technological debates that are set to ignite the industry’s most influential media, entertainment and technology event. With the conference and exhibition dates now aligned, all attendees will find inspiration in IBC’s world-class conference, which this year is themed Consumers First: A New Era in Media.

IBC’s Content Steering Group (CSG), a collection of industry experts and thought leaders from diverse industry sectors brought together by IBC, are the driving force behind this year’s conference, setting the agenda for a compelling event program that addresses the biggest opportunities and challenges faced by the industry.

Keynote speakers will set the tone for the entire event, examining t ... Read more »

The sponsorship marks the latest in a series of partnerships between the global beauty brand and scientific and academic communities

DALLAS-Monday 8 July 2019 [ AETOS Wire ]

(BUSINESS WIRE) -- Mary Kay Inc., a leading skincare innovator, continued its decades-long commitment to science through its sponsorship of the University of the Philippines Medical Alumni Society of America (UPMASA) 34th Annual Grand Convention (AGC) in Dallas. The conference, held at the Fairmont Hotel from July 2 – July 6, convened more than 500 doctors from the U.S. and the Philippines to discuss topics ranging from dermatology to orthopedics and neurology.

UPMASA is a non-profit organization that provides healthcare assistance and supports medical education in the Philippines. With 20 chapters and a membership base of over 2,000 medical doctors who are mostly in the USA and in the Philippines, members include those in clinical practice, research, academic medical educati ... Read more »

LACHEN, Switzerland-Monday 8 July 2019 [ AETOS Wire ]

(BUSINESS WIRE) -- Octapharma announced today that new data on the benefits of Nuwiq® in patients with haemophilia A were presented during a scientific symposium at the 27th International Society on Thrombosis and Haemostasis (ISTH) Congress in Melbourne, Australia. The symposium, entitled ‘Conveniently Protecting What Matters: Nuwiq® (Simoctocog Alfa) in PUPs and Personalised Prophylaxis’, focussed on addressing some of the most important clinical needs of people with haemophilia A, and included final data from the NuProtect Study in previously untreated patients (PUPs), which were presented for the first time. The symposium was chaired by Ellis J. Neufeld (St. Jude Children’s Research Hospital, Memphis, USA).

Larisa Belyanskaya, Head of the Octapharma’s Haematology International Business Unit stated “We are very pleased to present the final data from the NuProtect study in P ... Read more »